During the past decade, Florida Heart Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Florida Heart Associates" are "Atrial Fibrillation" (1 trials), "Atrial Flutter" (1 trials), "Coronary Artery Disease" (1 trials) and "Coronary Artery Disease (CAD)" (1 trials). Many other conditions were trialed in "Florida Heart Associates" in a lesser frequency.

Most popular intervention types in "Florida Heart Associates" are "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "99mTechnicium (sestamibi or tetrofosmin)" (1 trials), "Flurpiridaz F18" (1 trials), "Regadenoson" (1 trials), "Single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI)" (1 trials) and "apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Florida Heart Associates" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Florida Heart Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Florida Heart Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Florida Heart Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".